This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at email@example.com or call 800-767-3771 ext. 9339.
For Immediate Release
Chicago, IL – August 29, 2012 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Dell Inc. , Coinstar Inc. , WellPoint Inc. (WLP - Analyst Report), Wal-Mart Stores Inc. (WMT - Analyst Report) and Hewlett-Packard Company (HPQ - Analyst Report).
Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513
Here are highlights from Tuesday’s Analyst Blog:
Dell Inks OEM Deal with SoloHealth
Dell Inc. recently clinched an original equipment manufacturer (OEM) deal with healthcare kiosks provider SoloHealth Inc. The financial details of the deal have not been disclosed.
Atlanta-based SoloHealth specializes in providing interactive healthcare kiosks that help people to know their general health condition, free of cost. The kiosks record an individual’s health, gathering information such as blood pressure level, eyesight, weight, body mass index and so on. The database can then be used to consult a physician, enabling fast detection and prevention of disease. Being a start-up, the company has already attracted strategic investments from Coinstar Inc. and WellPoint Inc. (WLP - Analyst Report) to roll out a number of kiosks nationwide.
Under the terms of the agreement, Dell will manufacture high performance kiosks for SoloHealth. Those kiosks will be deployed at various important retail locations. Notably, SoloHealth has already clinched a deal with Wal-Mart Stores Inc. (WMT - Analyst Report).
Dell has been an experienced provider of OEM solutions to more than 2,100 customers, 40 different industry verticals including 30% of Fortune 100 companies. For the healthcare market, Dell’s solutions help to avoid overinvestment; save time and money in product development, reduce downtime and achieve longer product life-cycles. Dell’s technological expertise will help SoloHealth grow its market share through efficient kiosk performance.
We are encouraged by Dell’s deal winning momentum from various industry verticals. But the lackluster PC market, which is continually affecting the fundamentals, keeps us concerned. In its recently concluded second quarter results, Dell posted year-over-year decline in revenue and earnings per share.
A gloomy third quarter outlook, uncertainty regarding the acquisition of software vendor Quest Software and concerns regarding the PC market share loss to Hewlett-Packard Company (HPQ - Analyst Report) and other Asian manufacturers have led to our bearish view for the short term.
Currently, Dell has a Zacks #4 Rank, which implies a short-term Sell rating.
Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=5515.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=5517
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leon Zacks. As a PhD from MIT Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=5518.
Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
Zacks Investment Research
800-767-3771 ext. 9339